Geron (GERN) Price to FCF (2010 - 2026)
Geron's (GERN) quarterly Price to FCF came in at 51.96 in Q2 2026, down 58.34% year-over-year from 124.74 in Q2 2025, and down 242.84% quarter-over-quarter from 15.16 in Q1 2026.
Analysis
Geron (GERN) Price to FCF (2010 - 2026) Analysis & Trends
Geron has disclosed Price to FCF across 17 years of filings, most recently posting 51.96 for Q2 2026.
- In Q2 2026, Price to FCF fell 58.34% year-over-year to 51.96; the TTM figure through Jun 2026 stood at 7.19 (down 42.38% YoY), while the FY2025 annual figure was 7.61, up 22.29% from the prior year.
- Price to FCF came in at 51.96 for Q2 2026 at Geron, down from 15.16 in the prior quarter.
- In the past five years, Price to FCF ranged from a high of 12.44 in Q1 2022 to a low of 85.04 in Q4 2022.
- Average Price to FCF over 5 years is 36.86, with a median of 31.92 recorded in 2024.
- Year-over-year, Price to FCF sank 309.35% in 2022 and surged 67.02% in 2023.
- Over 5 years, Price to FCF stood at 85.04 in 2022, then surged by 67.02% to 28.04 in 2023, then slumped by 74.76% to 49.0 in 2024, then climbed by 21.9% to 38.27 in 2025, then plunged by 35.75% to 51.96 in 2026.
- Per Business Quant data, the three most recent Price to FCF figures were 51.96 in Q2 2026, 15.16 in Q1 2026, and 38.27 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.96 |
| Mar 31, 2026 | -15.16 |
| Dec 31, 2025 | -38.27 |
| Sep 30, 2025 | -64.42 |
| Jun 30, 2025 | -32.81 |
| Mar 31, 2025 | -21.11 |
| Dec 31, 2024 | -49.00 |
| Sep 30, 2024 | -46.56 |
| Jun 30, 2024 | -47.79 |
| Mar 31, 2024 | -31.03 |
| Dec 31, 2023 | -28.04 |
| Sep 30, 2023 | -22.56 |
| Jun 30, 2023 | -52.35 |
| Mar 31, 2023 | -24.84 |
| Dec 31, 2022 | -85.04 |
| Sep 30, 2022 | -18.36 |
| Jun 30, 2022 | -21.81 |
| Mar 31, 2022 | -12.44 |
| Dec 31, 2021 | -20.77 |
| Sep 30, 2021 | -19.04 |